These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 714310)

  • 21. [Vitamin K: biochemistry, function, and deficiency. Review].
    Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
    Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary vitamin K intake and stability of anticoagulation with coumarins: evidence derived from a clinical trial.
    Zuchinali P; Souza GC; de Assis MC; Rabelo ER; Rohde LE
    Nutr Hosp; 2012; 27(6):1987-92. PubMed ID: 23588449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Resistance to coumarin derivatives due to mutated vitamin-K enzyme].
    Hermans MH; Poodt J; van Geest-Daalderop JH; Péquériaux NC; Conemans JM
    Ned Tijdschr Geneeskd; 2009; 153():A691. PubMed ID: 19857286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vitamin K antagonists. (Part 1). Coumarin derivatives and analogues].
    RICHON J; LECONTE DES FLORIS R
    Concours Med; 1960 Oct; 82():4517-28. PubMed ID: 13741365
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
    Schurgers LJ; Spronk HM
    Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vitamin K antagonists].
    Lefrère JJ; Samama M
    Soins; 1987 Dec; (507):45-9. PubMed ID: 3438754
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vitamin K antagonists].
    Chabalier R; Lévy G
    Ann Anesthesiol Fr; 1978; 19(10):IN-5N. PubMed ID: 35048
    [No Abstract]   [Full Text] [Related]  

  • 28. [Metabolism of vitamin K antagonists].
    Blatrix C; Tillement JP
    Therapeutique; 1969 Nov; 45(9):875-7. PubMed ID: 5365412
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacodynamic and pharmacokinetic drug interactions with coumarin anticoagulants.
    MacLeod SM; Sellers EM
    Drugs; 1976; 11(6):461-70. PubMed ID: 782840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 32. Site-directed mutagenesis of coumarin-type anticoagulant-sensitive VKORC1: evidence that highly conserved amino acids define structural requirements for enzymatic activity and inhibition by warfarin.
    Rost S; Fregin A; Hünerberg M; Bevans CG; Müller CR; Oldenburg J
    Thromb Haemost; 2005 Oct; 94(4):780-6. PubMed ID: 16270630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA; Beaune P
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacodynamics of the oral anticoagulant drugs.
    O'Reilly RA
    Prog Hemost Thromb; 1974; 2(0):175-213. PubMed ID: 4137288
    [No Abstract]   [Full Text] [Related]  

  • 35. [Resistance to antivitamins K in man].
    Soulier JP; Blatrix C; Tillement JP
    Coeur Med Interne; 1967 Jan; 6(1):37-46. PubMed ID: 5596770
    [No Abstract]   [Full Text] [Related]  

  • 36. [Conditions of resistance to vitamin K antagonists].
    Marchal G; Samama M; Charon P
    Sem Ther; 1964 Dec; 40(10):623-7. PubMed ID: 5878936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug interactions with vitamin K antagonists].
    Thebault J; Tillement JP; Blatrix C
    Pathol Biol (Paris); 1973 Jun; 21(6):639-46. PubMed ID: 4581196
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathophysiology of vitamin K-deficiency and oral anticoagulants.
    Vermeer C; Hamulyák K
    Thromb Haemost; 1991 Jul; 66(1):153-9. PubMed ID: 1926045
    [No Abstract]   [Full Text] [Related]  

  • 39. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of vitamin K antagonist treatment on activated partial thromboplastin time.
    Mulliez SM; Van den Bogaert J; Devreese KM
    Clin Chem Lab Med; 2015 Feb; 53(2):e47-50. PubMed ID: 25153603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.